Corporate Services Center Receives LEED Silver Certification

Corporate Services Center Receives LEED Silver Certification

From left: Thomas C. Ahn, Vice President, Real Estate; Loida Ramos; and Kenneth Holden, Chief Facilities Officer, Department of Real Estate and Facilities

The Mount Sinai Health System’s new Corporate Services Center at 150 East 42nd Street has received Leadership in Energy and Environmental Design (LEED) Silver Certification from Green Business Certification Inc., a program that recognizes best-in-class building strategies and practices. Certification requires that building projects satisfy prerequisites in areas such as Indoor Environmental Quality, Water Efficiency, and Innovation in Design. “The LEED rating system aims to help owners be environmentally responsible and use resources efficiently,” says Loida Ramos, Vice President, Planning, Design and Construction. “LEED certification means healthier, more productive places, and reduced stress on the environment.”

Raising Awareness About Colon Cancer

The Mount Sinai Hospital’s Endoscopy Center team, along with Mount Sinai staff and volunteers and members of the Colon Cancer Challenge Foundation, in front of the “Rollin’ Colon” educational exhibit.

The Mount Sinai Hospital’s Endoscopy Center team, along with Mount Sinai staff and volunteers and members of the Colon Cancer Challenge Foundation, in front of the “Rollin’ Colon” educational exhibit.

Nearly 1,000 people participated in Colorectal Cancer Awareness Month activities on Wednesday, March 2, at The Mount Sinai Hospital. Visitors picked up educational literature and giveaways, and walked through a 30-ft. inflatable model of a colon, known as the “Rollin’ Colon”—provided by the Colon Cancer Challenge Foundation—that exhibits polyps and other signs of colon cancer. They also had the opportunity to talk with nurses, physicians, geneticists, nutritionists, and endoscopy staff. Forty seven attendees signed up for a screening colonoscopy. The event was hosted by The Mount Sinai Hospital Endoscopy Center.

Attacking Two Targets in Multiple Myeloma

Attacking Two Targets in Multiple Myeloma

Investigators, from left, Samir Parekh, MD; and Deepak Perumal, PhD

Research into a novel treatment that could help extend the lives of patients with multiple myeloma—a disease in which cancerous blood cells proliferate in the bone marrow—is being advanced by scientists at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, who recently identified a new drug target called ARK5.

The Mount Sinai scientists discovered that when ARK5 is targeted simultaneously with CDK4, a pathway widely known to have a role in inhibiting multiple myeloma, the results were extremely effective in causing cell death. Their findings were published in the March 15, 2016, issue of the journal Cancer Research. Read more

Medical Students Celebrate Match Day 2016

Medical Students Celebrate Match Day 2016

Celebrating their residency matches were, from left: Sonia Yen Jarrett, Children’s Hospital of Philadelphia (Pediatrics); Jake Goldman Prigoff, NewYork Presbyterian Hospital/Columbia University Medical Center (General Surgery); and Adam Fields, Brigham and Women’s Hospital (General Surgery).

The upbeat dance-pop song “Feel This Moment” was playing at full volume in the Annenberg West lobby on Friday, March 18, as graduating medical students opened their envelopes to learn which residency programs they would be attending during the next phase of their training. Joining them were family members, friends, and Mount Sinai Health System physicians and staff who shared in their energy and excitement, and offered hugs and congratulations during the annual Match Day event.

The Icahn School of Medicine at Mount Sinai’s graduating students were matched to residency programs throughout the country, including highly competitive ones at Brigham and Women’s Hospital, Hospital of the University of Pennsylvania, Yale-New Haven Hospital, Duke University Medical Center, and University of California San Francisco Medical Center. Fifty one students will remain within the Mount Sinai Health System to continue all or part of their graduate training. Read more

A New Data-Sharing Platform Developed at Mount Sinai Promises to Advance Digital Health Care

AppsLab-IMG_9289_wApp

Ashish Atreja, MD, MPH, center, with Bruce Darrow, MD, PhD, Associate Professor of Medicine (Cardiology) and Chief Medical Information Officer, Mount Sinai Health System, left, and Jagat Narula, MD, PhD, Associate Dean for Global Affairs, the Philip J. and Harriet L. Goodhart Professor of Medicine, and editorial board member of Mount Sinai’s upcoming Journal of Digital Medicine Evidence.

A new knowledge and data-sharing platform created by researchers at the Mount Sinai Health System is designed to help physicians weed through the thousands of mobile health apps that enter the market each year and identify the ones that successfully improve patient health. Called NODE Health (Network of Digital Evidence in Health), the platform was created by researchers at Mount Sinai’s AppLab, which is led by Ashish Atreja, MD, MPH, Chief Technology Innovation and Engagement Officer in the Department of Medicine, and Assistant Professor of Medicine (Gastroenterology). NODEHealth.org will provide physicians and other health care providers with an evidence-based review process and data-sharing network that is similar to ClinicalTrials.gov, enabling them to compare studies from around the world to find the health care apps that work best for their specialized needs. Read more

Defying the Odds and Rising to the Top

DR_PD SorosYou could say Denisse Rojas Marquez is a modern-day Phoenix: a woman who has overcome every obstacle life has thrown in her goal-oriented path with inspirational resilience and tenacity, defying the odds at every turn.

Despite being an undocumented immigrant and ineligible for financial aid, Denisse not only graduated from UC Berkeley—but also co-founded Pre-Health Dreamers (PHD) to provide resources and advocacy for other undocumented youth like herself. Today, as the first undocumented student to attend the Icahn School of Medicine at Mount Sinai (ISMMS), Denisse is one of 30 2016 recipients of The Paul & Daisy Soros Fellowship for New Americans. Read more

New Technology That Serves as an Artificial Pancreas Is Revolutionizing the Management of Type 1 Diabetes

New Technology That Serves as an Artificial Pancreas Is Revolutionizing the Management of Type 1 Diabetes

The AP (Artificial Pancreas) system runs an algorithm on a smartphone that communicates with an insulin pump and an implanted glucose sensor.

Research under way at the Icahn School of Medicine at Mount Sinai is revolutionizing the management of type 1 diabetes by using novel technology that serves as an artificial pancreas and automatically enables patients to achieve more stable glucose levels 24 hours a day.

Led by Carol Levy, MD, Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease), the Icahn School of Medicine is one of nine U.S. and European sites participating in the research, and sharing a $12.7 million grant from the National Institutes of Health. Dr. Levy is one of the study’s lead investigators. Read more

Living a Vibrant Life with Multiple Sclerosis

Catherine Roosevelt at the recent Fourteenth Annual Gala of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis.

Catherine Roosevelt at the recent Fourteenth Annual Gala of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis.

Catherine Roosevelt is a vibrant 30-year-old woman who is dedicated both to her career as the Advancement Director for a nonprofit organization serving girls living in poverty and to her numerous volunteer commitments. In a typical year, she travels an average of one weekend a month for work or volunteer service and spends a month every summer in Lake Placid, New York, co-directing a summer camp. Combined with a busy social life, her days and evenings can be stressful and tiring, but maintaining an active schedule validates a promise she made to herself six years ago, when she was diagnosed with multiple sclerosis (MS): “I won’t let my disease define me.” Read more

Breaking New Ground in Multiple Sclerosis Research

Researchers at Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis played a key role in developing a potential breakthrough treatment for progressive multiple sclerosis (MS), according to findings that were presented in October 2015 at the meeting of the European Committee for Treatment and Research in MS in Barcelona, Spain. The Center also recently received funding to lead a new international coalition tasked with developing a strategy for diagnosing progressive MS earlier. Both efforts further strengthen Mount Sinai’s reputation as a worldwide leader in MS research. Read more

Icahn School of Medicine Honors Two New Deans At Black History Month Celebration

Icahn School of Medicine Honors Two New Deans At Black History Month Celebration

From left: Reginald Miller, DVM; Dennis S. Charney, MD; and Gary Butts, MD, at the Honorary Deans’ Reception held during Black History Month.

During Black History Month in February, the Icahn School of Medicine at Mount Sinai honored its first black male deans, Gary C. Butts, MD, and Reginald Miller, DVM, for their significant contributions to the institution.

Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, spoke at the Honorary Deans’ Reception that was hosted by Mount Sinai’s Office for Diversity and Inclusion and Black Leaders Advocating for Change and Community, an employee resource group. Read more